References
- Davalinternational.com [Internet]. The website for Daval International Limited; 2010 [cited 2010 September 24]. Available from http://www.davalinternational.com/aimspro.php.
- Mackenzie R, Kiernan M, McKenzie D, Yourl BD. Hyperimmune goat serum for amyotrophic lateral sclerosis. J Clin Neurosci. 2006;13:1033–6.
- Youl BD, White SD, Cadogan M, Maizels DW, Brooman IC, Dalgleish AG. Goat serum product ”Aimspro” restores conduction in demyelinated human optic nerve fibers. J Clin Neurosci. 2006;13, Epub ahead of print 13 March 2006; withdrawn by authors 4 April 2006.
- Sutton I, Kermode A. Hyperimmune goat serum (Aimspro): hope or hype? J Clin Neurosci. 2006;13:1037–8.
- Burke G, Matthews P, Palace J. The evaluation of a novel ‘goat serum’ therapy (Aimspro) in multiple sclerosis. J Neurol Neurosurg Psych. 2006;17:1326.
- Mosley RL, Gendelman HE. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. Exp Neurol. 2010;222: 1–5.
- Cheah BC, Vucic S, Krishnan AV, Kiernan MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem. 2010;17:1942–1959.
- Mackenzie R. Follow-up study of hyperimmune goat serum (Aimspro) for amyotrophic lateral sclerosis. J Clin Neurosci. 2009;16:1508.
- Day TJ. Comment on: Follow-up study of hyperimmune goat serum (Aimspro) for amyotrophic lateral sclerosis. J Clin Neurosci. 2009;16:1509–11.
- Guardian.co.uk [Internet]. The website for the Guardian; 2010 [cited 2010 September 24]. Available from http://www.guardian.co.uk/uk/2007/jun/11/health.healthandwellbeing